Outcome of Board Meeting held on 4th September, 2025 at 04:00 P.M.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.0 pts more than Nifty Microcap 250 and 5.0 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of Transpact Enterprises Ltd held a meeting on 4th September 2025 from 4:00 PM to 4:30 PM. Key decisions include adoption of the Financial Statements, Annual Report, and Director's Report for FY ending 31st March 2025. The Board approved the re-appointment of Mr. Raman Talwar (Director, retiring by rotation) and the appointment of Ms. Priya Goel as an Independent Director, subject to shareholder approval. The Board also approved a change in the name of the Company, appointed M/s APNS And Associates as Secretarial Auditor for five years, and finalized the date and venue of the 12th Annual General Meeting along with the AGM notice.
The name change and new board appointments may signal a strategic shift or rebranding for shareholders, but without detailed financials disclosed here, near-term stock impact is likely limited. Investors should watch for further details in the AGM notice and the full Annual Report.